Asia's Biggest Drugmaker Eyes Greener Shores as Fortunes Fade at Home

Updated on

Christophe Weber and other gueats at the Takeda Innovation Networking reception in Boston.

Source: Takeda Pharmaceutical Co.

The balmy summer evening last year saw some of the most prolific biotech and scientific minds of Boston come together. There was the provost of MIT, enjoying the saxophone music alongside a U.S. congressman and senior venture capitalists. Their hosts: the Frenchman and the American tasked with turning around the fortunes of Asia’s largest drugmaker, Takeda Pharmaceutical Co.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.